Acotiamide PCD Pharma Franchise Company
Cafoli Lifecare offers the Actohub range of Acotiamide tablets for pharma distributors, medical agencies, stockists, and PCD franchise partners across India — covering both standard 100mg three-times-daily dosing and 300mg extended-release once-daily convenience.
What is Acotiamide?
Acotiamide is a gastroprokinetic agent that enhances acetylcholine release in the gut, improving gastric motility and accommodation. It is used for functional dyspepsia, relieving meal-related symptoms such as postprandial fullness, upper abdominal bloating, and early satiety (PubChem, NCBI).
Our Acotiamide Product Range
| Brand | Composition | Packing | MRP |
|---|
| Actohub 100 Tablet |
Acotiamide 100mg |
10×10 Alu Alu |
₹233 |
| Actohub 300 ER Tablet |
Acotiamide 300mg Extended Release |
10×1×10 Alu Alu |
₹420 |
Therapeutic Applications
Acotiamide serves functional dyspepsia management in gastroenterology and general practice. It fits prescriptions where acid suppressants alone fail to relieve motility-related symptoms, and is often co-prescribed with PPIs.
Why Acotiamide is a High-Potential Molecule for Distributors
Gastro is among the largest prescription categories in India, and functional dyspepsia affects a large share of urban patients. Acotiamide is a newer, focused therapy with limited brand competition in most districts — giving early distributors a first-mover advantage, especially with the once-daily ER format.
Why Choose Cafoli Lifecare
Monopoly rights based franchise model, WHO-GMP manufacturing, DCGI-approved portfolio, promotional inputs (visual aids, MR bags, product cards), fast dispatch, and competitive net rates — trusted by 1000+ franchise partners across India.
References
- NCBI PubChem — Acotiamide Compound Summary
- PubMed (U.S. National Library of Medicine) — Published research on Acotiamide
Our formulations of Acotiamide find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: